John Cogan, COO, Qinecsa outlines the opportunity presented by AI-driven automation to transform pharmacovigilance, both to address soaring workloads and costs, and to inject new strategic purpose into the function’s role.
dee karen Shutterstock
Powering the pharmacovigilance engine: why AI’s role is pivotal now
John Cogan, COO, Qinecsa outlines the opportunity presented by AI-driven automation to transform pharmacovigilance, both to address soaring workloads and costs, and to inject new strategic purpose into the function’s role.
Published:
|
3 min read
Last updated:
Sign up to our newsletter
The week's biggest stories from this industry, direct to your inbox.